U.S. Markets closed

Alliqua BioMedical, Inc. (ALQA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.27-0.01 (-3.57%)
At close: 4:00PM EDT
People also watch

Alliqua BioMedical, Inc.

1010 Stony Hill Road
Suite 200
Yardley, PA 19067
United States

IndustryDrug Manufacturers - Major
Full Time Employees81

Key Executives

Mr. David Ian JohnsonChief Exec. Officer, Pres, Director and Exec. Chairman of Aquamed Technologies Inc606.4kN/A59
Mr. Brian M. Posner CPA, MBA.Chief Financial Officer, Principal Accounting Officer, Treasurer and Sec.349.2kN/A55
Mr. Bradford C. BartonChief Operating Officer349.2kN/A57
Mr. Pellegrino PionatiChief Strategy & Marketing Officer349.2kN/A59
Dr. Phillip D. Forman M.D., DPMExec. VP of Clinical AffairsN/AN/A58
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Alliqua BioMedical, Inc., a regenerative technologies company, commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing; Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies; and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Alliqua BioMedical, Inc. has a license, marketing, development, and supply agreement with Anthrogenesis Corporation. The company is based in Yardley, Pennsylvania.

Corporate Governance

Alliqua BioMedical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.